These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 950465

  • 21. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ, Ai R, Ogata RT.
    J Immunol; 1999 Jun 01; 162(11):6580-8. PubMed ID: 10352274
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. C3 convertase of the human alternative pathway of complement: modulation of enzyme activity and stability by mouse monoclonal antibodies to Bb.
    Fishelson Z, Müller-Eberhard HJ.
    Eur J Immunol; 1987 Feb 01; 17(2):303-4. PubMed ID: 3644748
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH, Hänsch G, Gresham HD, Shin ML.
    J Immunol; 1983 Aug 01; 131(2):892-8. PubMed ID: 6863934
    [Abstract] [Full Text] [Related]

  • 27. Relative inefficiency of terminal complement activation.
    Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD.
    J Immunol; 1988 Nov 01; 141(9):3117-22. PubMed ID: 3262681
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

  • 30. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 31. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug 15; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 32. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM, Gleich GJ.
    J Immunol; 1988 Mar 01; 140(5):1605-10. PubMed ID: 3346544
    [Abstract] [Full Text] [Related]

  • 33. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    Fearon DT, Austen KF.
    J Exp Med; 1975 Oct 01; 142(4):856-63. PubMed ID: 1185108
    [Abstract] [Full Text] [Related]

  • 34. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO, Jaikaran AS, Carroll MC, Anderson MJ, Campbell RD, Isenman DE.
    J Immunol; 1992 May 01; 148(9):2803-11. PubMed ID: 1573269
    [Abstract] [Full Text] [Related]

  • 35. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 36. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 37. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    Schreiber RD, Medicus RG, Gïtze O, Müller-Eberhard HJ.
    J Exp Med; 1975 Sep 01; 142(3):760-72. PubMed ID: 1165475
    [Abstract] [Full Text] [Related]

  • 38. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 01; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 39. The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function.
    Daha MR, Austen KF, Fearon DT.
    J Immunol; 1977 Sep 01; 119(3):812-7. PubMed ID: 894027
    [No Abstract] [Full Text] [Related]

  • 40. Structure/function of C5 convertases of complement.
    Rawal N, Pangburn MK.
    Int Immunopharmacol; 2001 Mar 01; 1(3):415-22. PubMed ID: 11367526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.